Globus Medical Operating Income 2010-2025 | GMED
Globus Medical annual/quarterly operating income history and growth rate from 2010 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- Globus Medical operating income for the quarter ending March 31, 2025 was $0.097B, a 1113% increase year-over-year.
- Globus Medical operating income for the twelve months ending March 31, 2025 was $0.255B, a 200.93% increase year-over-year.
- Globus Medical annual operating income for 2024 was $0.166B, a 24.67% increase from 2023.
- Globus Medical annual operating income for 2023 was $0.133B, a 41.59% decline from 2022.
- Globus Medical annual operating income for 2022 was $0.228B, a 32.57% increase from 2021.
| Globus Medical Annual Operating Income (Millions of US $) |
|
|---|---|
| 2024 | $166 |
| 2023 | $133 |
| 2022 | $228 |
| 2021 | $172 |
| 2020 | $111 |
| 2019 | $172 |
| 2018 | $169 |
| 2017 | $162 |
| 2016 | $154 |
| 2015 | $172 |
| 2014 | $138 |
| 2013 | $102 |
| 2012 | $115 |
| 2011 | $97 |
| 2010 | $88 |
| 2009 | $82 |
| Globus Medical Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2025-03-31 | $97 |
| 2024-12-31 | $60 |
| 2024-09-30 | $48 |
| 2024-06-30 | $50 |
| 2024-03-31 | $8 |
| 2023-12-31 | $10 |
| 2023-09-30 | $0 |
| 2023-06-30 | $66 |
| 2023-03-31 | $56 |
| 2022-12-31 | $54 |
| 2022-09-30 | $60 |
| 2022-06-30 | $68 |
| 2022-03-31 | $46 |
| 2021-12-31 | $18 |
| 2021-09-30 | $53 |
| 2021-06-30 | $46 |
| 2021-03-31 | $55 |
| 2020-12-31 | $59 |
| 2020-09-30 | $50 |
| 2020-06-30 | $-26 |
| 2020-03-31 | $28 |
| 2019-12-31 | $50 |
| 2019-09-30 | $42 |
| 2019-06-30 | $43 |
| 2019-03-31 | $37 |
| 2018-12-31 | $43 |
| 2018-09-30 | $38 |
| 2018-06-30 | $42 |
| 2018-03-31 | $46 |
| 2017-12-31 | $48 |
| 2017-09-30 | $36 |
| 2017-06-30 | $37 |
| 2017-03-31 | $40 |
| 2016-12-31 | $36 |
| 2016-09-30 | $38 |
| 2016-06-30 | $38 |
| 2016-03-31 | $43 |
| 2015-12-31 | $56 |
| 2015-09-30 | $41 |
| 2015-06-30 | $37 |
| 2015-03-31 | $39 |
| 2014-12-31 | $40 |
| 2014-09-30 | $35 |
| 2014-06-30 | $32 |
| 2014-03-31 | $32 |
| 2013-12-31 | $32 |
| 2013-09-30 | $30 |
| 2013-06-30 | $11 |
| 2013-03-31 | $29 |
| 2012-12-31 | $29 |
| 2012-09-30 | $27 |
| 2012-06-30 | $31 |
| 2012-03-31 | $28 |
| 2011-12-31 | $24 |
| 2011-09-30 | $27 |
| 2011-06-30 | $24 |
| 2011-03-31 | $23 |
| 2010-12-31 | |
| 2009-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $7.316B | $2.519B |
| Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $182.012B | 22.03 |
| Intuitive Surgical (ISRG) | United States | $178.116B | 73.83 |
| Edwards Lifesciences (EW) | United States | $47.204B | 31.31 |
| IDEXX Laboratories (IDXX) | United States | $46.087B | 52.96 |
| Alcon (ALC) | Switzerland | $45.102B | 30.48 |
| DexCom (DXCM) | United States | $35.035B | 54.15 |
| IQVIA Holdings (IQV) | United States | $33.074B | 18.69 |
| Mettler-Toledo (MTD) | United States | $26.313B | 31.29 |
| STERIS (STE) | Ireland | $22.465B | 24.74 |
| Waters (WAT) | United States | $18.043B | 25.46 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.167B | 0.00 |
| Hologic (HOLX) | United States | $14.717B | 15.99 |
| Sysmex ADR (SSMXY) | Japan | $10.575B | 30.00 |
| Penumbra (PEN) | United States | $8.797B | 64.71 |
| Masimo (MASI) | United States | $8.618B | 31.79 |
| Glaukos (GKOS) | United States | $5.358B | 0.00 |
| Teleflex (TFX) | United States | $5.103B | 8.42 |
| Integer Holdings (ITGR) | United States | $3.826B | 19.09 |
| TransMedics (TMDX) | United States | $3.546B | 77.08 |
| PROCEPT BioRobotics (PRCT) | United States | $2.979B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.399B | 14.28 |
| Nihon Kohden (NHNKY) | Japan | $2.020B | 23.17 |
| Elekta AB (EKTAY) | Sweden | $1.937B | 17.41 |
| Veracyte (VCYT) | United States | $1.916B | 26.89 |
| Alphatec Holdings (ATEC) | United States | $1.590B | 0.00 |
| Artivion (AORT) | United States | $1.345B | 126.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.112B | 0.00 |
| OPKO Health (OPK) | United States | $1.071B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.999B | 5.31 |
| Pulse Biosciences (PLSE) | United States | $0.990B | 0.00 |
| SiBone (SIBN) | United States | $0.759B | 0.00 |
| IRadimed (IRMD) | United States | $0.735B | 37.29 |
| Beta Bionics (BBNX) | United States | $0.636B | 0.00 |
| AxoGen (AXGN) | United States | $0.612B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.548B | 8.53 |
| OrthoPediatrics (KIDS) | United States | $0.541B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.505B | 10.86 |
| Pacific Biosciences Of California (PACB) | United States | $0.462B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.452B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.422B | 9.82 |
| Delcath Systems (DCTH) | United States | $0.380B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.371B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.352B | 0.00 |
| RxSight (RXST) | United States | $0.318B | 0.00 |
| Neuronetics (STIM) | United States | $0.296B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.295B | 0.00 |
| NeuroPace (NPCE) | United States | $0.288B | 0.00 |
| 908 Devices (MASS) | United States | $0.249B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.246B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.240B | 14.52 |
| CVRx (CVRX) | United States | $0.215B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.202B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.179B | 0.00 |
| Inogen (INGN) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.164B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Accuray (ARAY) | United States | $0.154B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.121B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.119B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.117B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.115B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.088B | 53.30 |
| EnVVeno Medical (NVNO) | United States | $0.086B | 0.00 |
| Hyperfine (HYPR) | United States | $0.082B | 0.00 |
| InspireMD (NSPR) | United States | $0.075B | 0.00 |
| Spectral AI (MDAI) | United States | $0.064B | 0.00 |
| Positron (POSC) | United States | $0.060B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.055B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.054B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.052B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.022B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.013B | 0.00 | |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 14.94 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |